proteon xpr36 spr protein interaction array system (Bio-Rad)
Bio-Rad is a verified supplier 
Bio-Rad manufactures this product 
96
Structured Review
Bio-Rad
proteon xpr36 spr protein interaction array system
Proteon Xpr36 Spr Protein Interaction Array System, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 565 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proteon+xpr36+system/ProteOn+XPR36+Protein+Interaction+Array+System/pmc13136073-412-6-13
Average 96 stars, based on 565 article reviews
Proteon Xpr36 Spr Protein Interaction Array System, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 565 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proteon+xpr36+system/ProteOn+XPR36+Protein+Interaction+Array+System/pmc13136073-412-6-13
Average 96 stars, based on 565 article reviews
proteon xpr36 spr protein interaction array system - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Binding Assay:Article Title: Potent inhibition of MMP-9 by a novel sustained-release platform attenuates left ventricular remodeling following myocardial infarction. Article Snippet: Sustained drug-release systems prolong the retention of therapeutic drugs within target tissues to alleviate the need for repeated drug administration.. Two major caveats of the current systems are that the release rate and the timing cannot be predicted or fine-tuned because they rely on uncontrolled environmental conditions and that the system must be redesigned for each drug and treatment regime because the drug is bound via interactions that are specific to its structure and composition.. We present a controlled and universal sustained drug-release system, which comprises minute spherical particles in which a therapeutic protein is affinity-bound to alginate sulfate (AlgS) through one or more short heparin-binding peptide (HBP) sequence repeats. Article Title: Targeted delivery and pro-apoptotic efficacy of an Epstein-Barr virus nuclear antigen 1-specific affibody in EBV-infected cells in vitro. Article Snippet: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article.. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Article Title: Virus glycoprotein nanodisc platform for vaccine design Article Snippet: .. The kinetics and binding affinities of antibody-antigen interactions were analyzed using either SPR Assay:Article Title: Potent inhibition of MMP-9 by a novel sustained-release platform attenuates left ventricular remodeling following myocardial infarction. Article Snippet: Sustained drug-release systems prolong the retention of therapeutic drugs within target tissues to alleviate the need for repeated drug administration.. Two major caveats of the current systems are that the release rate and the timing cannot be predicted or fine-tuned because they rely on uncontrolled environmental conditions and that the system must be redesigned for each drug and treatment regime because the drug is bound via interactions that are specific to its structure and composition.. We present a controlled and universal sustained drug-release system, which comprises minute spherical particles in which a therapeutic protein is affinity-bound to alginate sulfate (AlgS) through one or more short heparin-binding peptide (HBP) sequence repeats. Article Title: Targeted delivery and pro-apoptotic efficacy of an Epstein-Barr virus nuclear antigen 1-specific affibody in EBV-infected cells in vitro. Article Snippet: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article.. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Article Title: Molecular forms of BMP15 and GDF9 in mammalian species that differ in litter size. Article Snippet: The purified hBMPR2 receptor domain was N-biotinylated using EZ-Link sulfo-NHS-LC-biotin (Pierce) in 1:1.2 molar ratio as previously described55. .. Surface plasmon resonance analyses were performed using a Article Title: FcRn-silencing of IL-12Fc prevents toxicity of local IL-12 therapy and prolongs survival in experimental glioblastoma Article Snippet: .. SPR was performed using the Article Title: Molecular forms of BMP15 and GDF9 in mammalian species that differ in litter size Article Snippet: The purified hBMPR2 receptor domain was N- biotinylated using EZ-Link sulfo-NHS-LC-biotin (Pierce) in 1:1.2 molar ratio as previously described . .. Surface plasmon resonance analyses were performed using a Article Title: Tau oligomers impair memory and synaptic plasticity through the cellular prion protein Article Snippet: .. SPR analysis was carried out with a Article Title: Antibodies that specifically bind PD-1 and methods of use Article Snippet: .. Affinity Measurements Using Surface Plasmon Resonance (SPR) Affinity measurements were performed using a Spectroscopy:Article Title: Potent inhibition of MMP-9 by a novel sustained-release platform attenuates left ventricular remodeling following myocardial infarction. Article Snippet: Sustained drug-release systems prolong the retention of therapeutic drugs within target tissues to alleviate the need for repeated drug administration.. Two major caveats of the current systems are that the release rate and the timing cannot be predicted or fine-tuned because they rely on uncontrolled environmental conditions and that the system must be redesigned for each drug and treatment regime because the drug is bound via interactions that are specific to its structure and composition.. We present a controlled and universal sustained drug-release system, which comprises minute spherical particles in which a therapeutic protein is affinity-bound to alginate sulfate (AlgS) through one or more short heparin-binding peptide (HBP) sequence repeats. Recombinant:Article Title: FcRn-silencing of IL-12Fc prevents toxicity of local IL-12 therapy and prolongs survival in experimental glioblastoma Article Snippet: .. SPR was performed using the |